Novartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market

Following the palmy spin-off of its Sandoz generics part successful precocious 2023, Novartis AG (NYSE:NVS) has transformed into a high-margin, pure-play innovative medicines institution that is presently outpacing its peers successful some pipeline velocity and superior efficiency. In aboriginal 2026, Novartis reported that its halfway maturation drivers, Kisqali (breast cancer), Kesimpta (multiple sclerosis), and Pluvicto (radioligand therapy), were seeing explosive growth. Specifically, Kisqali income surged by 57% and Pluvicto by 42% successful changeless currencies, providing the high-growth kicker that elite investors look for. The steadfast has built a monolithic competitory moat successful radioligand therapy. With the FDA-approved Millburn installation scaling up successful aboriginal 2026, the institution is efficaciously the person of this high-margin crab attraction niche.

READ ALSO: D. E. Shaw Stock Portfolio: Top 10 Stocks to Buy.

Novartis AG (NYSE:NVS) banal offers utility-like information combined with tech-like margins. The institution achieved a 40.1% halfway operating borderline successful 2025/2026, an elite fig that provides a monolithic buffer against inflationary pressures and R&D costs. It generated $17.6 cardinal successful escaped currency travel past year. This liquidity allows it to money mid-sized bolt-on acquisitions, similar the $2 cardinal Excellergy woody successful March 2026, without stressing its equilibrium expanse oregon taking connected unsafe debt. Novartis is simply a premier income sanctuary. In aboriginal 2026, it projected a dividend of CHF 3.70 per share, a 5.7% increase, yielding astir 3%. It has a decades-long way grounds of uninterrupted payouts, providing a reliable paycheck for diligent holders.

While we admit the imaginable of NVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Israel Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Disclosure: None. Follow Insider Monkey connected Google News.